SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,878 JPY | +1.54% |
|
-4.62% | +1.18% |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| May. 13 | Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial | RE |
| Sales 2024 | 435B 2.78B | Sales 2025 * | 424B 2.71B | Capitalization | 1,920B 12.25B |
|---|---|---|---|---|---|
| Net income 2024 | 162B 1.03B | Net income 2025 * | 148B 946M | EV / Sales 2024 | 5.05 x |
| Net cash position 2024 * | 473B 3.02B | Net cash position 2025 * | 521B 3.32B | EV / Sales 2025 * | 3.3 x |
| P/E ratio 2024 |
13.9
x | P/E ratio 2025 * |
13
x | Employees | 4,959 |
| Yield 2024 * |
2.36% | Yield 2025 * |
2.34% | Free-Float | 87.27% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +1.54% | ||
| 1 week | -4.62% | ||
| Current month | -6.73% | ||
| 1 month | -6.33% | ||
| 3 months | -6.47% | ||
| 6 months | -2.44% | ||
| Current year | +1.18% |
1 week
6 729.00
7 258.00
1 month
6 729.007 650.00
Current year
6 729.008 137.00
1 year
5 718.008 137.00
3 years
5 438.008 439.00
5 years
4 379.008 439.00
10 years
1 930.008 439.00
| Managers | Title | Age | Since |
|---|---|---|---|
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Yuji Hosogai
DFI | Director of Finance/CFO | - | - |
Yasuetsu Imune
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroshi Ozaki
BRD | Director/Board Member | 74 | 19-05-31 |
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Takuko Sawada
BRD | Director/Board Member | 69 | 77-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 19 M€ | +9.53% | ||
| 2.51% | 7 M€ | +9.05% | - | |
| 1.07% | 57 M€ | +18.31% | ||
| 1.05% | 10 M€ | +17.08% | - | |
| 1.04% | 240 M€ | +17.47% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 6,878 | +1.54% | 1 408 700 |
| 24-05-22 | 6,774 | -3.71% | 1,724,100 |
| 24-05-21 | 7,035 | -1.53% | 1,015,800 |
| 24-05-20 | 7,144 | +0.21% | 914,500 |
| 24-05-17 | 7,129 | -1.14% | 725,400 |
Delayed Quote Japan Exchange, May 23, 2024 at 02:00 am EDT
More quotes
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-06-06
- R&D Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
6,774
JPY
Average target price
7,867
JPY
Spread / Average Target
+16.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.18% | 12.27B | |
| +37.74% | 723B | |
| +34.65% | 595B | |
| -2.07% | 369B | |
| +20.25% | 332B | |
| +2.99% | 282B | |
| +17.11% | 244B | |
| +10.02% | 208B | |
| -4.13% | 205B | |
| +7.43% | 166B |
- Stock Market
- Equities
- 4507 Stock
